Solid financials. Expanding product line. Way undervalued.

Solid management...good company. Some debt issues but they should be worked out over the course of this year.

Great new IPO. They have some great porject that they are working on. Good presence around the world. Some compare ACM to a young Foster Wheeler. Only time will tell.

Looking to expand troughout the east coast...undervalued. Should be headed toward 30$

Watch this one as they continue to pick up new contracts.

Needle free injection. This product should be in every pediatricians office. Managment seems kinda slow on things. Listen to the conference calls first.

Overseas growth. People just have to have their Starbucks coffee.